Cleveland Diagnostics is developing technology to evaluate the changes to the structure of the protein biomarker. These structural changes directly relate to cancer mutations.

In contrast to looking at gene mutations (which evaluate your risk of getting a disease), Cleveland Diagnostics’ technology provides direct information about the onset or progression of that disease.

Industry Sector
Biomedical & Health Tech

Founded
2013

JumpStart Investment
Evergreen Fund